🇺🇸 FDA
Patent

US 11459373

Anti-VEGF protein compositions and methods for producing the same

granted A61KA61K38/179A61K38/1866

Quick answer

US patent 11459373 (Anti-VEGF protein compositions and methods for producing the same) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/179, A61K38/1866, A61P, A61P17/06